Featured Video

Featured Video

Mechanism of Action
See how FLOSEAL works to stop bleeding fast

Needle-free Simplicity

Needle-free Simplicity

Everything you expect from FLOSEAL - except the needle

FLOSEAL vs flowable hemostats

Cardiac Study Results

In 2014, a large observational database study was done to analyze “real world” outcomes of flowable hemostatic matrices among a cardiac surgery population, where different bleeds types are more numerous and the severity of bleeding during surgical cases can be aggressive.1 The results showed statistically signifcant advantages for patients treated with FLOSEAL compared to SURGIFLO with thrombin:

  • LESS risk of transfusion
  • LESS major and minor complications
  • LESS surgery time
VS flowable hemostats
VS flowable hemostats

Spine Study Results

In order to understand if the performance difference found between FLOSEAL and SURGIFLO w/ Thrombin in prior studies would be transferable to a surgical population with less aggressive bleeds (ranging from broad diffuse mild capillary oozing to moderately brisk bleeds), a similar observational analysis among a large spine surgery population was conducted. This study looked at major and severe spine surgeries, and results showed statistically significant advantages for patients treated with FLOSEAL compared to SURGIFLO w/Thrombin:2

  • LESS volume of product utilized in the major surgery group
  • LESS surgery time in both major and severe surgery groups
  • LESS risk of transfusion in the major surgery group

AVERAGE AMOUNT OF PRODUCT USED

Average amount of product used

It is more likely that only one 10 mL FLOSEAL syringe is necessary vs. two 8 mL syringes of SURGIFLO w/Thrombin.

*No significant differences observed for severe surgery

MEAN SURGERY TIME

Mean surgery time
Mean surgery time
  1. Tackett SM, Calcattera D, Magee G, Lattouf CM. Real world outcomes of hemostatic matrices in cardiac surgery. J Cariothorac Vasc Anesth. 2014;28:1558-65.
  2. Price JS, Tackett S, Patel V. Observational evaluation of outcomes and resource utilization from hemostatic matrices in spine surgery. J Med Econ. 2015; Jun 1:1-10.